On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 12:00 Today
- Snap falls -40.3%
- 10:00 Today
- Snap falls -38.8%
- 09:47 Today
- Snap falls -37.0%
- 05/23/22
- Snap continues to slide, now down 29% to $15.85
- $179.56 /
-16.615 (-8.47%) - 05/23/22
- Instagram rolls out 'Visual Refresh'
- 05/23/22
- DC AG sues Mark Zuckerberg over Cambridge Analytica scandal
- 05/18/22
- NY AG launches probes into social media companies following Buffalo shooting
- 05/18/22
- Tesla ineligible for S&P 500 ESG Index inclusion, S&P announces
- $2,100.99 /
-128.33 (-5.76%) - 08:04 Today
- Pegasystems announces partnership with Google Cloud
- 05/20/22
- Match Group withdraws request for temporary restraining order against Google
- 05/19/22
- AMD selects Google Cloud to provide additional scale for chip design workloads
- 05/17/22
- Google introduces Assured Open Source Software service
- 05/23/22
- Cathie Wood's ARK Investment bought 99.4K shares of Zoom Video today
- 05/23/22
- Zoom Video jumps 16% to $103.60 after Q1 earnings beat, FY23 guidance raise
- 05/16/22
- Tiger Global buys Starry, exits Adobe in Q1
- 05/12/22
- Zoom Video enters agreement to acquire Solvvy
- 04/20/22
- Best Buy launches home pick-up recycling service
- 04/07/22
- Best Buy CEO: Our purpose is to enrich lives through technology
- 03/03/22
- Best Buy increases quarterly dividend 26%, announces $5B share repurchase plan
- 02/03/22
- Best Buy selects AWS as preferred cloud provider
- $290.04 /
-33.88 (-10.46%) - 04/01/22
- DexCom to launch Dexcom One Continuous Glucose Monitoring System in UK
- 03/25/22
- DexCom announces four-for-one forward stock split
- 03/14/22
- DexCom announces CE Mark for G7 Continuous Glucose Monitoring System
- 03/07/22
- DexCom: Ontario government to provide coverage for Dexcom G6 CGM System
- $216.50 /
+13.415 (+6.61%) - 05/05/22
- Insulet CEO Shacey Petrovic steps down
- 05/05/22
- Insulet affirms FY22 revenue growth view of 12%-16%
- 05/05/22
- Insulet sees Q2 revenue up 12%-15%
- 01/28/22
- Insulet announces FDA clearance of Omnipod 5 for ages six and older
- 09:31 Today
- Ralph Lauren expects all 3 regions to drive positive revenue growth this year
- 09:25 Today
- Ralph Lauren sees growth in owned and wholesale digital in FY23
- 09:23 Today
- Ralph Lauren: Foreign tourism remains 'muted'
- 09:21 Today
- Ralph Lauren sees FY23 marketing about 6%-7% of sales
- 12:00 Today
- Abercrombie & Fitch falls -30.4%
- 10:00 Today
- Abercrombie & Fitch falls -25.5%
- 09:47 Today
- Abercrombie & Fitch falls -26.9%
- 03/31/22
- Netflix teases trailer for documentary on 'rise and fall' of Abercrombie & Fitch
- 05/19/22
- Marqeta adds Evolve Bank & Trust as bank partner for program management
- 05/13/22
- Soros buys Lucid, exits GM in Q1
- 05/12/22
- Marqeta trading resumes
- 05/12/22
- Marqeta trading halted, volatility trading pause
- 05/16/22
- Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe
- 05/16/22
- Tiger Global buys Starry, exits Adobe in Q1
- 03/29/22
- Snowflake extends relationship with AWS
- 03/06/22
- Fly Intel: Top five weekend stock stories
- 05/10/22
- Roblox reports April revenue $189M-$192M, up 30%-32% y/y
- 05/10/22
- Roblox reports Q1 DAUs up 28% y/y
- 05/04/22
- Spotify introduces 'Spotify Island' on Roblox
- 04/21/22
- Cathie Wood's ARK Investment bought 339K shares of Roblox today
- 05/02/22
- Eaton to acquire 50% stake in Jiangsu Huineng Electric's circuit breaker unit
- 04/04/22
- Eaton names Heath Monesmith President and Chief Operating Officer
- 02/23/22
- Eaton boosts quarterly dividend by 7% to 81c per share
- 01/05/22
- Eaton completes acquisition of Royal Power Solutions for $600M
- 05/20/22
- HLVX Stock trading resumes
- 05/20/22
- HLVX Stock trading halted, volatility trading pause
- 05/02/22
- HilleVax initiates Phase 2b trial of HIL-214 vaccine candidate
- 06:48 Today
- Merck: EC approves KEYTRUDA plus chemotherapy for treatment of TNBC
- 05/20/22
- Merck announces CHMP recommendation for approval of Keytruda
- 05/18/22
- IO Biotech announces initiation of Phase 3 trial of IOB102-IOB103, KEYTRUDA
- 05/16/22
- Neoleukin treats first patient in Phase 1 trial of NL-201 w/ KEYTRUDA
- 08:41 Today
- Moderna says investigating potential monkeypox vaccines at 'preclinical level'
- 08:21 Today
- Rubius Therapeutics appoints Noubar Afeyan as chairman of the board
- 05/18/22
- Moderna, IAVI launch clinical trial of mRNA HIV vaccine antigen in Africa
- 05/17/22
- Moderna announces research findings at Science and Technology Day
- 05/23/22
- Broadcom delivers 50G Automotive Ethernet Switch
- 05/22/22
- Fly Intel: Top five weekend stock stories
- 05/06/22
- TD Synnex secures cybersecurity aggregator agreement with Broadcom
- 05/03/22
- Broadcom announces opportunities for solutions with Z16 Mainframe
- 05/23/22
- VMware rises 20.8%
- 05/23/22
- VMware rises 19.6%
- 05/23/22
- VMware rises 17.8%
- 05/22/22
- Fly Intel: Top five weekend stock stories
- $649.05 /
-25.825 (-3.83%) - 05/23/22
- Cathie Wood's ARK Investment bought 15.9K shares of Tesla today
- 05/20/22
- Elon Musk: We will never surrender/settle an unjust case against us
- 05/20/22
- Musk denies he sexually harassed flight attendant on private jet
- 05/19/22
- Tesla investor calls on company to buy back shares
- 02/09/22
- Nautilus expects to return to positive adjusted EBITDA in FY23
- 05/11/22
- Albemarle announces pricing of public offering of senior notes
- 05/05/22
- Albemarle rises 9.7%
- 04/29/22
- Albemarle announces Maria Brennan as chief supply chain officer
- 04/08/22
- Musk says Tesla may need to get into lithium mining
- 05/23/22
- Advance Auto Parts reports Q1 SSS up 0.6% and up 25.3% on two-year stack
- 04/20/22
- Advance Auto Parts, L.A. Dodgers announce exclusive partnership
- 03/16/22
- Advance Auto Parts appoints Signet Jewelers executive Joan Hilson to board
- 02/14/22
- Advance Auto Parts raises quarterly dividend 50% to $1.50 per share
- 08:06 Today
- Honeywell to help customers achieve carbon neutrality
- 06:11 Today
- Honeywell sees long-term organic sales growth 4%-7%
- 06:11 Today
- Honeywell committed to deploying $25B+ over next three years
- 05/23/22
- Lilium partners with Honeywell, Denso on electric motor for its jet engines
- 08:11 Today
- Petco jumps 5% to $15.35 after Q1 results top estimates
- 05/09/22
- PetMed Express appoints Carden as VP of Product Management
- 05/05/22
- Butterfly Network, Petco announce technology collaboration
- 05/02/22
- Petco announces Backcountry x Petco pet gear collection
- 06:05 Today
- MannKind's Technosphere inhalation platform utilized in FDA-approved Tyvaso DPI
- 05/17/22
- MannKind to acquire Zealand Pharma's V-Go for $10M
- 04/06/22
- United Therapeutics' Tyvaso DPI shows safety and tolerability in PAH
- 02/24/22
- MannKind provides update on Tyvaso DPI new drug application
- 06:05 Today
- MannKind's Technosphere inhalation platform utilized in FDA-approved Tyvaso DPI
- 06:02 Today
- United Therapeutics announces FDA approval of Tyvaso DPI
- 05/23/22
- United Therapeutics' NDA for Tyvaso DPI approved by FDA
- 04/06/22
- United Therapeutics' Tyvaso DPI shows safety and tolerability in PAH
- 06:08 Today
- Dermavant Sciences announces FDA approval of VTAMA cream, 1%
- 05/16/22
- Aruvant announces oral presentation on ARU-1801
- 05/02/22
- Roivant Sciences announces collaborations in targeted protein degradation
- 05/02/22
- Roivant Sciences appoints Srini Ramanathan as CDO
- 05/12/22
- Fisker to produce Fisker PEAR in Ohio
- 05/04/22
- Fisker sees opex and capex within prior forecast range of $715M-$790M
- 05/04/22
- Fisker announces third vehicle, Project Ronin
- 04/12/22
- Fisker selects Hyderabad as headquarters for initial India operations
SWTX SpringsWorks Therapeutics - 06:32 Today
- SpringsWorks Therapeutics: Nirogacestat achieved endpoints in Phase 3 DeFi trial
- 04/19/22
- SpringsWorks announces agreeement with Regeneron for nirogacestat
- 12/10/21
- SpringsWorks Therapeutics announces trial collaboration with AbbVie
- 12/06/21
- SpringsWorks Therapeutics doses first patient in Phase 1b/2 nirogacestat study
- $2,104.00 /
-128.15 (-5.74%) - 08:04 Today
- Pegasystems announces partnership with Google Cloud
- 05/20/22
- Match Group withdraws request for temporary restraining order against Google
- 05/19/22
- AMD selects Google Cloud to provide additional scale for chip design workloads
- 05/17/22
- Google introduces Assured Open Source Software service
- 05/18/22
- Tesla ineligible for S&P 500 ESG Index inclusion, S&P announces
- 05/11/22
- J&J appoints Thibaut Mongon as CEO Designate of new consumer health company
- 05/05/22
- FDA limits authorized use of J&J's COVID vaccine
- 05/02/22
- FDA announces tentative advisory committee meetings on COVID-19 vaccines
- 06:47 Today
- Pfizer announces ELEVATE UC Phase 3 results
- 05/23/22
- Pfizer, BioNTech vaccine demonstrates strong immune response in Phase 2/3 trial
- 05/17/22
- Pfizer, BioNTech receive FDA emergency use authorization for child booster
- 05/17/22
- FDA expands eligibility for Pfizer-BioNTech booster to kids 5-11 years old
- 08:59 Today Truist
- Snap price target lowered to $33 from $60 at Truist
- 08:35 Today Oppenheimer
- Snap price target lowered to $30 from $40 at Oppenheimer
- 08:18 Today MKM Partners
- Snap price target lowered to $26 from $41 at MKM Partners
- 08:12 Today Jefferies
- Alphabet price target lowered to $3,100 from $3,400 at Jefferies
- $179.56 /
-16.615 (-8.47%) - 08:10 Today Jefferies
- Meta Platforms price target lowered to $310 from $330 at Jefferies
- 07:11 Today BofA
- Snap price target lowered to $30 from $50 at BofA
- 06:32 Today KeyBanc
- Snap price target lowered to $27 from $45 at KeyBanc
- 04:46 Today Piper Sandler
- Snap price target lowered to $30 from $50 at Piper Sandler
- $2,100.99 /
-128.33 (-5.76%) - 08:12 Today Jefferies
- Alphabet price target lowered to $3,100 from $3,400 at Jefferies
- 07:11 Today BofA
- Snap price target lowered to $30 from $50 at BofA
- 06:32 Today KeyBanc
- Snap price target lowered to $27 from $45 at KeyBanc
- 04:46 Today Piper Sandler
- Snap price target lowered to $30 from $50 at Piper Sandler
- 08:30 Today Morgan Stanley
- Zoom rebutted 'overwhelmingly negative sentiment' with Q1, says Morgan Stanley
- 08:20 Today Stifel
- Zoom Video price target lowered to $120 from $150 at Stifel
- 07:26 Today Benchmark
- Zoom Video price target raised to $128 from $124 at Benchmark
- 06:58 Today Citi
- Zoom Video price target lowered to $99 from $118 at Citi
- 05/19/22 Truist
- Best Buy price target lowered to $83 from $117 at Truist
- 05/16/22 Wedbush
- Best Buy price target lowered to $80 from $110 at Wedbush
- 05/13/22 Citi
- Best Buy price target lowered to $80 from $100 at Citi
- 03/04/22 Raymond James
- Raymond James downgrades Best Buy on 'very challenging' setup
- $290.04 /
-33.88 (-10.46%) - 10:09 Today Stifel
- Market needs more time to digest possible DexCom deal, says Stifel
- 08:00 Today BofA
- DexCom, Insulet deal 'seems unlikely at first glance,' says BofA
- 07:45 Today Canaccord
- Insulet/Dexcom deal would form tantalizing giant in diabetes, says Canaccord
- 04:43 Today Piper Sandler
- Piper skeptical of potential Insulet acquisition by DexCom
- $216.50 /
+13.415 (+6.61%) - 10:09 Today Stifel
- Market needs more time to digest possible DexCom deal, says Stifel
- 08:00 Today BofA
- DexCom, Insulet deal 'seems unlikely at first glance,' says BofA
- 07:45 Today Canaccord
- Insulet/Dexcom deal would form tantalizing giant in diabetes, says Canaccord
- 04:43 Today Piper Sandler
- Piper skeptical of potential Insulet acquisition by DexCom
- 05/23/22 Citi
- Ralph Lauren downgraded to Neutral from Buy at Citi
- 05/18/22 Credit Suisse
- Ralph Lauren price target lowered to $130 from $165 at Credit Suisse
- 05/16/22 Deutsche Bank
- Ralph Lauren price target lowered to $116 from $136 at Deutsche Bank
- 04/05/22 Wells Fargo
- Ralph Lauren downgraded to Equal Weight from Overweight at Wells Fargo
- 05/23/22 Citi
- Abercrombie & Fitch downgraded to Neutral from Buy at Citi
- 05/16/22 JPMorgan
- Abercrombie & Fitch price target raised to $39 from $35 at JPMorgan
- 04/11/22 JPMorgan
- Abercrombie & Fitch price target lowered to $35 from $41 at JPMorgan
- 03/16/22 B. Riley
- B. Riley says teen/young adult apparel 'poised for a breakout'
- 06:20 Today Morgan Stanley
- Morgan Stanley upgrades Marqeta to Overweight on attractive entry point
- 05:13 Today Morgan Stanley
- Marqeta upgraded to Overweight from Equal Weight at Morgan Stanley
- 05/17/22 Mizuho
- Marqeta price target lowered to $12 from $17 at Mizuho
- 05/12/22 Truist
- Marqeta price target lowered to $16 from $20 at Truist
- 07:02 Today BTIG
- Snowflake price target lowered to $183 from $359 at BTIG
- 05:21 Today Rosenblatt
- Snowflake upgraded to Buy into Q1 results at Rosenblatt
- 05:15 Today Rosenblatt
- Snowflake upgraded to Buy from Neutral at Rosenblatt
- 05/23/22 Jefferies
- Snowflake price target lowered to $150 from $230 at Jefferies
- 08:08 Today Atlantic Equities
- Atlantic downgrades Roblox on softening app trends, halves target
- 05:11 Today Atlantic Equities
- Roblox downgraded to Neutral from Overweight at Atlantic Equities
- 05/17/22 Daiwa
- Roblox price target lowered to $38 from $56 at Daiwa
- 05/12/22 Needham
- Roblox price target lowered to $40 from $60 at Needham
- 07:27 Today Barclays
- Eaton downgraded to Underweight from Equal Weight at Barclays
- 05/17/22 Morgan Stanley
- Eaton price target raised to $180, named a 'Top Pick' at Morgan Stanley
- 05/04/22 Wells Fargo
- Eaton price target raised to $159 from $149 at Wells Fargo
- 05/04/22 Mizuho
- Eaton price target lowered to $185 from $195 at Mizuho
- 07:36 Today Guggenheim
- Guggenheim starts HilleVax at Buy on norovirus vaccine potential
- 06:23 Today SVB Leerink
- HilleVax initiated with an Outperform at SVB Leerink
- 06:22 Today Guggenheim
- HilleVax initiated with a Buy at Guggenheim
- 05:50 Today Stifel
- HilleVax initiated with a Buy at Stifel
- 04/12/22 Barclays
- Merck price target raised to $97 from $94 at Barclays
- 04/11/22 H.C. Wainwright
- Rubius Therapeutics price target lowered to $15 from $40 at H.C. Wainwright
- 04/06/22 Morgan Stanley
- Merck assumed with an Equal Weight at Morgan Stanley
- 04/05/22 BMO Capital
- Merck targets 'ambitious' $10B revenue from cardiovascular franchise, says BMO
- 05/17/22 Piper Sandler
- Moderna price target lowered to $214 from $348 at Piper Sandler
- 04/20/22 Piper Sandler
- Piper says 'do not be fooled,' Arcturus Phase 3 shows strong vaccine efficacy
- 04/19/22 Piper Sandler
- Moderna's bivalent booster improves titers against omicron, says Piper Sandler
- 04/11/22 Piper Sandler
- CFO leaves Dentsply for Moderna, outside replacement more likely, says Piper
- 06:17 Today Mizuho
- Broadcom could triple software revenue with VMware, says Mizuho
- 04:39 Today Piper Sandler
- Broadcom deal for VMware 'makes perfect sense,' says Piper Sandler
- 05/23/22 BofA
- Deal for VMware would be synergistic with Broadcom strategy, says BofA
- 05/23/22 Piper Sandler
- VMware passes Broadcom deal 'smell-test,' says Piper Sandler
- 06:17 Today Mizuho
- Broadcom could triple software revenue with VMware, says Mizuho
- 04:39 Today Piper Sandler
- Broadcom deal for VMware 'makes perfect sense,' says Piper Sandler
- 05/23/22 Jefferies
- VMware price target lowered to $105 from $125 at Jefferies
- 05/23/22 RBC Capital
- VMware price target lowered to $140 from $153 at RBC Capital
- $649.05 /
-25.825 (-3.83%) - 07:33 Today Wedbush
- More fireworks expected heading into Twitter shareholder meeting, says Wedbush
- 06:20 Today Bernstein
- Bernstein says Tesla-Twitter saga far from over, discusses funding requirements
- 05:48 Today Daiwa
- Tesla price target lowered to $800 from $1,150 at Daiwa
- 05/23/22 Mizuho
- Nio could be back to pre-shutdown levels by June, says Mizuho
- 09:06 Today Lake Street
- Nautilus price target lowered to $5 from $14 at Lake Street
- 08:48 Today Truist
- Nautilus price target lowered to $5 from $15 at Truist
- 08:31 Today Craig-Hallum
- Craig-Hallum downgrades Nautilus to Hold, lowers price target to $2
- 07:27 Today Craig-Hallum
- Nautilus downgraded to Hold from Buy at Craig-Hallum
- 06:51 Today BMO Capital
- BMO Capital sees 'strong value' in Albemarle after guidance raise
- 06:49 Today Deutsche Bank
- Albemarle price target raised to $320 from $290 at Deutsche Bank
- 06:46 Today Wells Fargo
- Albemarle price target raised to $320 from $285 at Wells Fargo
- 06:23 Today RBC Capital
- Albemarle price target raised to $314 from $300 at RBC Capital
- 07:30 Today Wedbush
- Advance Auto Parts price target lowered to $215 from $270 at Wedbush
- 06:42 Today Wells Fargo
- Advance Auto Parts price target lowered to $200 from $230 at Wells Fargo
- 05/16/22 Wells Fargo
- Advance Auto Parts price target lowered to $230 from $245 at Wells Fargo
- 05/13/22 Citi
- Advance Auto Parts price target lowered to $250 from $294 at Citi
- 05/02/22 Wells Fargo
- Honeywell price target raised to $203 from $196 at Wells Fargo
- 05/02/22 Citi
- Honeywell price target raised to $232 from $229 at Citi
- 04/14/22 Deutsche Bank
- Honeywell price target lowered to $230 from $243 at Deutsche Bank
- 04/14/22 Deutsche Bank
- Honeywell named short-term buy idea at Deutsche Bank
- 05/23/22 Baird
- Baird a buyer into Petco Q1 results as shares offer good value
- 05/20/22 Needham
- Petco seen as 'safe place to hide' on replenishment demand, says Needham
- 05/20/22 Jefferies
- Pet specialty retail selloff overdone, says Jefferies
- 05/16/22 Morgan Stanley
- Petco initiated with an Equal Weight at Morgan Stanley
- 02/28/22 H.C. Wainwright
- MannKind price target lowered to $6 from $6.50 at H.C. Wainwright
- 11/11/21 H.C. Wainwright
- MannKind price target raised to $6.50 from $6 at H.C. Wainwright
- 07:46 Today Jefferies
- United Therapeutics price target raised to $245 from $223 at Jefferies
- 07:42 Today JPMorgan
- United Therapeutics price target raised to $238 from $225 at JPMorgan
- 07:27 Today Wedbush
- United Therapeutics price target raised to $263 from $236 at Wedbush
- 06:28 Today Credit Suisse
- United Therapeutics price target raised to $247 from $219 at Credit Suisse
- 05/23/22 SVB Leerink
- Roivant Sciences initiated with an Outperform at SVB Leerink
- 04/29/22 Cantor Fitzgerald
- Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
- 12/15/21 Goldman Sachs
- Roivant Sciences initiated with a Buy at Goldman Sachs
- 12/02/21 H.C. Wainwright
- H.C. Wainwright says Arbutus patent win may mean 'considerable gain' for Roivant
- 04/27/22 Jefferies
- Frontline reinstated with a Hold at Jefferies
- 04/27/22 Jefferies
- Euronav NV downgraded to Hold at Jefferies after merger announcement
- 04/08/22 H.C. Wainwright
- Frontline price target raised to $9 from $8 at H.C. Wainwright
- 06/30/21 Danske Bank
- Frontline upgraded to Buy from Hold at Danske Bank
- 05/17/22 Credit Suisse
- Fisker price target lowered to $20 from $25 at Credit Suisse
- 05/05/22 Cowen
- Fisker price target lowered to $19 from $28 at Cowen
- 05/05/22 Barclays
- Fisker price target lowered to $14 from $16 at Barclays
- 05/05/22 Citi
- Fisker price target lowered to $27 from $29 at Citi
SWTX SpringsWorks Therapeutics - 10:44 Today Goldman Sachs
- SpringsWorks Therapeutics price target raised to $82 from $76 at Goldman Sachs
- 03/01/22 H.C. Wainwright
- SpringsWorks Therapeutics price target raised to $142 from $137 at H.C. Wainwright
- 10/27/21 Wedbush
- Wedbush recommends buying SpringsWorks shares ahead of BLENREP combo data
- 09/08/21 JPMorgan
- SpringsWorks price target raised to $105 from $97 at JPMorgan
- $2,104.00 /
-128.15 (-5.74%) - 08:12 Today Jefferies
- Alphabet price target lowered to $3,100 from $3,400 at Jefferies
- 07:11 Today BofA
- Snap price target lowered to $30 from $50 at BofA
- 06:32 Today KeyBanc
- Snap price target lowered to $27 from $45 at KeyBanc
- 04:46 Today Piper Sandler
- Snap price target lowered to $30 from $50 at Piper Sandler
- 05/23/22 SVB Leerink
- Johnson & Johnson assumed with an Outperform at SVB Leerink
- 05/17/22 BofA
- Teva upgraded to Neutral at BofA on potential opioid deal upside
- 05/17/22 Citi
- Johnson & Johnson price target lowered to $205 from $210 at Citi
- 04/29/22 Chardan
- Emergent BioSolutions price target lowered to $65 from $75 at Chardan
- 05/23/22 Piper Sandler
- Biohaven price target lowered to $149 from $170 at Piper Sandler
- 05/23/22 SVB Leerink
- Pfizer initiated with a Market Perform at SVB Leerink
- 05/11/22 H.C. Wainwright
- Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright
- 05/11/22 Wedbush
- Global Blood Therapeutics added to Best Ideas List at Wedbush
- 05/23/22
- Snap sees Q2 revenue, adjusted EBITDA below low end of prior guidance
- 04/21/22
- Snap sees Q2 revenue up 20%-25% y/y, consensus $1.26B
- 04/21/22
- Snap reports Q1 EPS (2c), consensus 1c
- 04/21/22
- Notable companies reporting after market close
- $179.56 /
-16.615 (-8.47%) - 04/27/22
- Meta sees Q2 revenue $28B-$30B, consensus $30.63B
- 04/27/22
- Meta Platforms reports Q1 EPS $2.72, consensus $2.56
- 04/27/22
- Notable companies reporting after market close
- 02/02/22
- Meta sees Q1 revenue $27B-29B, consensus $30.14B
- $2,100.99 /
-128.33 (-5.76%) - 04/26/22
- Alphabet reports Q1 EPS $24.62, consensus $25.96
- 04/26/22
- Notable companies reporting after market close
- 02/01/22
- Alphabet reports Q4 EPS $30.69, consensus $27.32
- 02/01/22
- Notable companies reporting after market close
- 05/23/22
- Zoom Video raises FY23 EPS view to $3.70-$3.77 from $3.45-$3.51
- 05/23/22
- Zoom Video sees Q2 EPS 90-92c, consensus 88c
- 05/23/22
- Zoom Video reports Q1 EPS $1.03, consensus 87c
- 05/23/22
- Notable companies reporting after market close
- 07:06 Today
- Best Buy cuts FY23 EPS view $8.40-$9.00 from $8.85-$9.15, consensus $8.90
- 07:04 Today
- Best Buy reports Q1 EPS $1.57, consensus $1.61
- 05/23/22
- Notable companies reporting before tomorrow's open
- 05/23/22
- Notable companies reporting before tomorrow's open
- $290.04 /
-33.88 (-10.46%) - 04/28/22
- DexCom reports Q1 EPS 93c, consensus 52c
- 02/10/22
- DexCom sees FY22 revenue $2.82B-$2.94B, consensus $2.96B
- 02/10/22
- DexCom reports Q4 EPS 68c, consensus 85c
- 02/10/22
- Notable companies reporting after market close
- $216.50 /
+13.415 (+6.61%) - 05/05/22
- Insulet reports Q1 EPS 40c, consensus 23c
- 02/23/22
- Insulet sees FY22 revenue up 12%-16%
- 02/23/22
- Insulet sees Q1 revenue up 13%-16%
- 02/23/22
- Insulet reports Q4 EPS 42c, consensus 32c
- 09:31 Today
- Ralph Lauren currently sees FY23 revenue up about 8%, consensus $6.38B
- 08:09 Today
- Ralph Lauren sees FY23 revenue up high single digits, consensus $6.38B
- 08:07 Today
- Ralph Lauren sees Q1 revenue up 8%, consensus $1.42B
- 08:04 Today
- Ralph Lauren reports Q4 adjusted EPS 49c, consensus 38c
- 07:37 Today
- Abercrombie & Fitch sees Q2 net sales down low-single-digits, consensus $888.38M
- 07:35 Today
- Abercrombie & Fitch sees 2022 net sales flat to up 2%, consensus $3.84B
- 07:33 Today
- Abercrombie & Fitch reports Q1 adjusted EPS (27c), consensus 8c
- 03/02/22
- Abercrombie & Fitch sees 2022 net sales up 2%-4% vs. 2021
- 05/11/22
- Marqeta sees Q2 revenue growth 46%-48%, consensus $167.74M
- 05/11/22
- Marqeta reports Q1 EPS (11c), consensus (8c)
- 05/11/22
- Notable companies reporting after market close
- 03/09/22
- Marqeta sees FY22 revenue up at least mid-30% range, consensus $661.31M
- 03/02/22
- Snowflake sees FY23 product revenue $1.88B-$1.9B
- 03/02/22
- Snowflake reports Q4 EPS (43c), consensus 3c
- 03/02/22
- Notable companies reporting after market close
- 12/01/21
- Snowflake reports Q3 EPS (51c), consensus (6c)
- 05/10/22
- Roblox reports Q1 EPS (27c), consensus (21c)
- 05/10/22
- Notable companies reporting after market close
- 02/15/22
- Roblox reports Q4 EPS (25c), consensus (13c)
- 02/15/22
- Notable companies reporting after market close
- 05/03/22
- Eaton sees Q2 adjusted EPS $1.78-$1.88, consensus $1.83
- 05/03/22
- Eaton raises FY22 adjusted EPS view to $7.32-$7.72 from $7.30-$7.70
- 05/03/22
- Eaton reports Q1 adjusted EPS $1.62, consensus $1.60
- 02/04/22
- Eaton sees Q1 adjusted EPS $1.55-$1.65, consensus $1.63
- 04/28/22
- Merck raises FY22 adjusted EPS view to $7.24-$7.36, consensus $7.24
- 04/28/22
- Merck reports Q1 adjusted EPS $2.14, consensus $1.83
- 04/27/22
- Notable companies reporting before tomorrow's open
- 04/27/22
- Notable companies reporting before tomorrow's open
- 05/04/22
- Moderna reports Q1 GAAP EPS $8.58, consensus $5.21
- 05/03/22
- Notable companies reporting before tomorrow's open
- 05/03/22
- Notable companies reporting before tomorrow's open
- 02/24/22
- Moderna reports Q4 GAAP EPS $11.29, consensus $9.90
- 03/03/22
- Broadcom sees Q2 revenue $7.9B, consensus $7.43B
- 03/03/22
- Broadcom reports Q1 adjusted EPS $8.39, consensus $8.08
- 03/03/22
- Notable companies reporting after market close
- 12/09/21
- Broadcom sees Q1 revenue $7.6B, consensus $7.25B
- 02/24/22
- VMware sees FY23 EPS $6.97, consensus $7.29
- 02/24/22
- VMware sees Q1 EPS $1.56, consensus $1.64
- 02/24/22
- VMware reports Q4 adjusted EPS $2.02, consensus $1.97
- 02/24/22
- Notable companies reporting after market close
- $649.05 /
-25.825 (-3.83%) - 04/20/22
- Tesla reports Q1 EPS $3.22, consensus $2.26
- 04/20/22
- Notable companies reporting after market close
- 01/26/22
- Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26
- 01/26/22
- Notable companies reporting after market close
- 05/23/22
- Nautilus sees FY23 revenue $380M-$460M, consensus $521.77M
- 05/23/22
- Nautilus sees Q1 sales $45M-$55M
- 05/23/22
- Nautilus reports Q4 EPS (58c), consensus (58c)
- 02/09/22
- Nautilus reports Q3 EPS (43c), consensus (49c)
- 05/23/22
- Albemarle raises FY22 net cash from operations view to $550M-$850M
- 05/23/22
- Albemarle raises FY22 adjusted EPS view to $12.30-$15.00 from $9.25-$12.25
- 05/04/22
- Albemarle raises FY22 adjusted EPS view to $9.25-$12.25 from $5.65-$6.65
- 05/04/22
- Albemarle reports Q1 adjusted EPS $2.38, consensus $1.63
- 05/23/22
- Advance Auto Parts raises FY22 EPS view to $13.30-$13.85 from $13.20-$13.75
- 05/23/22
- Advance Auto Parts reports Q1 adjusted EPS $3.57, consensus $3.60
- 05/23/22
- Notable companies reporting after market close
- 02/14/22
- Advance Auto Parts sees FY22 adjusted EPS $13.20-$13.75, consensus $13.27
- 06:10 Today
- Honeywell reaffirms FY22 adjusted EPS view $8.50-$8.80, consensus $8.72
- 06:10 Today
- Honeywell reaffirms Q2 adjusted EPS view $1.98-$2.08, consensus $2.03
- 04/29/22
- Honeywell sees Q2 adjusted EPS $1.98-$2.08, consensus $2.04
- 04/29/22
- Honeywell raises FY22 adjusted EPS view to $8.50-$8.80 from $8.40-$8.70
- 07:32 Today
- Petco backs FY22 adjusted EPS 97c-$1.00, consensus 99c
- 07:30 Today
- Petco reports Q1 adjusted EPS 17c, consensus 15c
- 05/23/22
- Notable companies reporting before tomorrow's open
- 05/23/22
- Notable companies reporting before tomorrow's open
- 05/05/22
- MannKind reports Q1 EPS (10c), consensus (10c)
- 02/24/22
- MannKind reports Q4 EPS (11c), consensus (6c)
- 05/04/22
- United Therapeutics reports Q1 EPS $5.03, consensus $3.34
- 02/24/22
- United Therapeutics reports Q4 non-GAAP EPS $3.51, consensus $3.72
- 02/14/22
- Roivant Sciences reports Q4 EPS (41c), consensus (25c)
- 08:57 Today
- Frontline reports Q1 adjusted EPS (1c), consensus (30c)
- 02/17/22
- Frontline reports Q4 adjusted EPS (2c) vs. (18c) last quarter
- 11/29/21
- Frontline reports Q3 adjusted EPS (18c) vs. (12c) last quarter
- 05/04/22
- Fisker reports Q1 EPS (41c), consensus (39c)
- 05/04/22
- Notable companies reporting after market close
- 02/16/22
- Fisker reports Q4 EPS (47c), consensus (47c)
- 02/16/22
- Notable companies reporting after market close
SWTX SpringsWorks Therapeutics - 05/05/22
- SpringsWorks Therapeutics reports Q1 EPS ($1.26), consensus ($1.02)
- 02/24/22
- SpringsWorks Therapeutics reports Q4 EPS ($1.15), consensus (88c)
- $2,104.00 /
-128.15 (-5.74%) - 04/26/22
- Alphabet reports Q1 EPS $24.62, consensus $25.96
- 04/26/22
- Notable companies reporting after market close
- 02/01/22
- Alphabet reports Q4 EPS $30.69, consensus $27.32
- 02/01/22
- Notable companies reporting after market close
- 04/19/22
- Johnson & Johnson cuts FY22 adj. EPS view to $10.15-$10.35 from $10.40-$10.60
- 04/19/22
- Johnson & Johnson reports Q1 adjusted EPS $2.67, consensus $2.61
- 04/18/22
- Notable companies reporting before tomorrow's open
- 04/18/22
- Notable companies reporting before tomorrow's open
- 05/03/22
- Pfizer cuts FY22 adjusted EPS view to $6.25-$6.45 from $6.35-$6.55
- 05/03/22
- Pfizer reports Q1 adjusted EPS $1.62, consensus $1.47
- 05/02/22
- Notable companies reporting before tomorrow's open
- 05/02/22
- Notable companies reporting before tomorrow's open
|
On The Fly
| ShowHide Related Items >><< - 05/09/22
- Blackstone announces former Zynga COO Matthew Bromberg as senior advisor
- 05/03/22
- Match Group says Shar to step down as CEO, Bernard Kim to succeed
- $122.46 /
-1.175 (-0.95%) - 05/19/22
- Take-Two, Zynga stockholders approve proposals related to pending transaction
- 05/17/22
- Take-Two CEO: We had great launches, great results in Q4
- 05/10/22
- Nintendo sold 235.1M Switch software copies in FY ended March
- 05/04/22
- U.S. video game spending falls 8% y/y in Q1, says NPD
- 05/19/22
- CD Projekt says next-gen 'Witcher 3' version to release in 4Q22
- 05/19/22
- National Research Corporation appoints Parul Bhandari to board
- 05/19/22
- Itron expands collaboration with Microsoft on cloud solutions for energy
- 05/18/22
- American Airlines to use Microsoft Azure as its preferred cloud platform
- 05/13/22
- 'LEGO Star Wars' was best-selling game in April in U.S., says NPD
- 05/13/22
- U.S. video game spending fell 8% y/y in April, says NPD
- 05/12/22
- EA says 'Dead Space' remake out January 27, 2023
- 05/10/22
- Electronic Arts raises quarterly dividend to 19c from 17c per share
- 05/22/22
- Fly Intel: Top five weekend stock stories
- 05/18/22
- Genius Brands signs 20-year deal with Marvel Studies to license 'Stan Lee'
- 05/17/22
- Disney, XFL reach exclusive, global multi-year broadcast agreement
- 05/15/22
- Fly Intel: Top five weekend stock stories
- 05/03/22
- NBC News says parts of 11 articles were plagiarized
- 05/01/22
- Fly Intel: Top five weekend stock stories
- 04/26/22
- Nintendo says 'Mario Bros.' movie pushed by Spring 2023
- 05/14/22
- Trian exits Comcast position, increases stake in Invesco
- 05/12/22
- Marcien Jenckes named president of Comcast, Charter joint venture
- 05/09/22
- Comcast announces additional efforts for Affordable Connectivity Program
- 05/09/22
- Internet providers join President Biden's Affordable Connectivity Program
- 05/13/22
- Soros buys Lucid, exits GM in Q1
- $2,027.13 /
-125.73 (-5.84%) - 05/19/22
- Elastic expands collaboration with Amazon Web Services for Elastic Cloud
- 05/18/22
- NY AG launches probes into social media companies following Buffalo shooting
- 05/18/22
- Amazon hit with pregnancy, disability discrimination complaint in New York
- 05/16/22
- Berkshire Hathaway adds Citi, exits Wells Fargo in Q1
- 05/16/22
- Soros Capital buys Suncor and Mosaic during Q1, exits Alphabet
- 05/11/22
- Google Maps debuts new 'immersive view' for cities in Google Maps
- 05/10/22
- Apple says iPod touch will be 'available while supplies last'
- 05/23/22 Jefferies
- Odds favor no EA deal over a deal for next several quarters, says Jefferies
- 05/23/22 Raymond James
- Electronic Arts moves 'somewhat unexpected,' says Raymond James
- 05/17/22 Morgan Stanley
- Take-Two price target lowered to $195 from $215 at Morgan Stanley
- 05/11/22 Wells Fargo
- Electronic Arts price target lowered to $145 from $155 at Wells Fargo
- 05:55 Today Daiwa
- Disney price target lowered to $151 from $201 at Daiwa
- 05/23/22 KGI Securities
- Disney initiated with an Outperform at KGI Securities
- 07:15 Today BofA
- Apple App Store growth has re-accelerated modestly, says BofA
- 06:41 Today Benchmark
- Snap price target lowered to $20 from $40 at Benchmark
- 05/23/22 UBS
- UBS finds solid iPhone purchase demand in China, modest U.S. downtick for Apple
- $2,027.13 /
-125.73 (-5.84%) - 05/20/22 Citi
- Amazon.com removed from Focus List at Citi
- 05/10/22 Morgan Stanley
- Expectations for Affirm outlook 'meaningfully' lower, says Morgan Stanley
- 05/10/22 Morgan Stanley
- Morgan Stanley sees 300% upside potential for Rivian in base case
- 05/06/22 Truist
- Cable One price target lowered to $1,400 from $2,000 at Truist
- 04/29/22 Morgan Stanley
- Comcast price target lowered to $55 from $60 at Morgan Stanley
- 04/14/22 Oppenheimer
- Comcast price target lowered to $60 from $75 at Oppenheimer
- 03/23/22 Craig-Hallum
- ComScore poised for share gains in local measurement, says Craig-Hallum
- 05/23/22 Jefferies
- Microsoft price target lowered to $325 from $400 at Jefferies
- 05/23/22 RBC Capital
- Upwork initiated with a Sector Perform at RBC Capital
- 05/19/22 RBC Capital
- Microsoft investor meetings indicate no change to macro/demand, says RBC Capital
- 05/13/22 Tigress Financial
- Microsoft pullback 'major buying opportunity,' says Tigress Financial
- 05/06/22 Benchmark
- Playstudios could still be target as industry consolidates, says Benchmark
- 04/25/22 Benchmark
- Activision results for Blizzard 'somewhat shocking,' says Benchmark
- 04/19/22 Goldman Sachs
- Activision Blizzard assumed with Not Rated at Goldman Sachs
- 02/28/22 Benchmark
- Playstudios could be target as game industry consolidates, says Benchmark
- $122.46 /
-1.175 (-0.95%) - 05/17/22 Oppenheimer
- Take-Two price target lowered to $190 from $215 at Oppenheimer
- 05/17/22 Jefferies
- Take-Two guidance 'better than feared,' says Jefferies
- 05/17/22 Wedbush
- Take-Two price target lowered to $145 from $180 at Wedbush
- 04/19/22 Goldman Sachs
- Zynga assumed with Not Rated at Goldman Sachs
- 09:38 Today CLSA
- Nintendo price target lowered to 51,000 yen from 53,000 yen at CLSA
- 03/23/22 Macquarie
- Nintendo upgraded to Outperform from Neutral at Macquarie
- 02/16/22 Jefferies
- Nintendo upgraded to Buy from Hold at Jefferies
- 11/05/21 Macquarie
- Nintendo downgraded to Neutral from Outperform at Macquarie
- 05/09/22
- Zynga reports Q1 EPS (2c), consensus 9c
- 05/09/22
- Notable companies reporting after market close
- 02/09/22
- Zynga reports Q4 EPS (6c), consensus 9c
- $122.46 /
-1.175 (-0.95%) - 05/16/22
- Take-Two sees Q1 GAAP EPS 80c-90c, consensus 90c
- 05/16/22
- Take-Two sees FY23 GAAP EPS $1.90-$2.15, consensus $5.99
- 05/16/22
- Take-Two sees FY23 net bookings $3.75B-$3.85B, consensus $4.01B
- 05/16/22
- Take-Two reports Q4 GAAP EPS 95c, consensus $1.04
- 05/10/22
- Nintendo reports FY revenue Y1.70T vs. Y1.8T last year
- 02/03/22
- Nintendo sees FY profit per share Y3,388.54, net sales Y1.65T
- 02/03/22
- Nintendo reports 9 months profit per share Y3,106.05 vs. Y3,161.97 last year
- 04/26/22
- Microsoft sees Q4 productivity and business processes revenue $16.65B-$16.9B
- 04/26/22
- Microsoft reports Q3 EPS $2.22 consensus $2.18
- 04/26/22
- Notable companies reporting after market close
- 01/25/22
- Microsoft reports Q2 EPS $2.48, consensus $2.31
- 05/10/22
- Electronic Arts sees Q1 EPS 76c-85c, consensus 83c
- 05/10/22
- Electronic Arts sees FY23 EPS $2.79-$2.87, consensus $7.43
- 05/10/22
- Electronic Arts reports Q4 EPS 80c, consensus $1.43
- 05/10/22
- Notable companies reporting after market close
- 05/11/22
- Disney reports Q2 EPS ex-items $1.08, consensus $1.17
- 05/11/22
- Notable companies reporting after market close
- 02/09/22
- Disney reports Q1 EPS ex-items $1.06, consensus 57c
- 02/09/22
- Notable companies reporting after market close
- 04/28/22
- Comcast reports Q1 adjusted EPS 86c, consensus 80c
- 04/27/22
- Notable companies reporting before tomorrow's open
- 01/27/22
- Comcast reports Q4 adjusted EPS 77c, consensus 73c
- 04/25/22
- Activision Blizzard reports Q1 EPS 64c, consensus 70c
- 02/03/22
- Activision Blizzard reports Q4 adjusted EPS $1.01, consensus $1.31
- 02/03/22
- Notable companies reporting after market close
- $2,027.13 /
-125.73 (-5.84%) - 05/05/22
- AES Corp.to provide 450 MW of renewable energy to Amazon
- 04/28/22
- Amazon sees Q2 revenue $116B-$121B, consensus $125.55B
- 04/28/22
- Amazon reports Q1 EPS ($7.56) with Rivian expense, consensus $8.36
- 04/28/22
- Apple says y/y Q3 revenue growth to be impacted by COVID
- 04/28/22
- Apple reports Q2 EPS $1.52, consensus $1.43
- 04/28/22
- Notable companies reporting after market close
- 02/27/22
- Berkshire operating earnings surge, Buffett repurchases record $27B in stock
- 02/09/22
- Zynga sees first NFT game to be released this year, Axios reports
- 01/31/22
- Sony's Ryan says people 'should expect more' gaming M&A, Gamesindustry.biz says
- 01/22/22
- Many ways to play Microsoft, Activision Blizzard deal, Barron's says
- 01/15/22
- Take-Two playing the long game, stock looks cheap, Barron's says
- $122.46 /
-1.175 (-0.95%) - 03/28/22
- New 'Kirby' biggest release in franchise in U.K. history, Gamesindustry.biz says
- 03/07/22
- Take-Two halts new game sales in Russia, Belarus, Verge reports
- 03/03/22
- 'Elden Ring' has biggest U.K. launch since last 'COD,' Gamesindustry.biz says
- 05/18/22
- Saudi Arabia's PIF acquires 5.01% stake in Nintendo, Bloomberg reports
- 05/16/22
- 'Switch Sports' top U.K. boxed game seller again, Gamesindustry.biz says
- 05/09/22
- 'Switch Sports' still at the top in U.K. boxed sales, Gamesindustry.biz says
- 06:14 Today
- Activision studio workers vote to unionize, NY Times reports
- 05/19/22
- Microsoft president says Activision Blizzard deal proceeding quickly, VGC says
- 05/19/22
- Xbox Series S outsold PlayStation 5 in Japan last week, Famitsu reports
- 05/23/22
- Electronic Arts reportedly looking to sell or merge, Kotaku reports
- 04/25/22
- BioWare contractors preparing union vote, Kotaku reports
- 04/14/22
- 'Elden Ring' top-selling game in Europe in March, Gamesindustry.biz says
- 04/01/22
- ESA cancels digital E3 2022 event, IGN reports
- 05/02/22
- Disney's corporate affairs head Geoff Morrell exits, WSJ reports
- 05/01/22
- Disney's clash with Florida has CEOs on alert, WSJ reports
- 04/28/22
- ESPN anchor Steele sues network, alleges violation of free-speech, WSJ reports
- 03/10/22
- Nintendo theme park coming to Universal Studios Hollywood next year, Verge says
- 03/04/22
- NBCUniversal ends Hulu next-day TV show deal, Variety reports
- 04/19/22
- Users report issues with Hulu, DownDetector says
- 04/01/22
- WWE producing two traditional tv shows about wrestling, WSJ reports
- 03/30/22
- Hulu loses Paramount, MGM films as EPIX deal ends, The Streamable says
- 06:33 Today
- NLRB says Activision Blizzard illegally threatened staff, Reuters reports
- $2,027.13 /
-125.73 (-5.84%) - 06:04 Today
- Investors to challenge Amazon on pay, working conditions, FT reports
- 05/22/22
- Amazon aims to sublet, end warehouse leases, Bloomberg reports
- 05/18/22
- Amazon sought to avoid probes of some drone crashes, Insider reports
- 05/16/22
- Starbucks to reimburse U.S. workers traveling to obtain abortions, Reuters says
- 05/23/22
- Apple to release new HomePod in 4Q22 or 1Q23, MacRumors reports
- 05/22/22
- Apple looking to boost production outside China, WSJ reports
- 05/19/22
- Apple previewed mixed-reality headset to board, Bloomberg reports
- 03/04/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/15/22
- Game On: January U.S. game spending slips 2% year-over-year
- $122.46 /
-1.175 (-0.95%) - 05/17/22
- What You Missed On Wall Street On Tuesday
- 05/17/22
- What You Missed On Wall Street This Morning
- 05/03/22
- What You Missed This Week in Video Games
- 05/19/22
- What You Missed On Wall Street On Thursday
- 05/17/22
- What You Missed This Week in Video Games
- 05/12/22
- What You Missed On Wall Street This Morning
- 10:41 Today
- What You Missed This Week in Video Games
- 05/23/22
- What You Missed On Wall Street On Monday
- 05/23/22
- What You Missed On Wall Street This Morning
- 05/23/22
- Fly Intel: Pre-market Movers
- 05/22/22
- Box Office Battle: 'Doctor Strange 2' wins weekend with another $31.6M
- 05/16/22
- Wall Street calls out this stock as a winner from Netflix adding ads
- 05/08/22
- Box Office Battle: 'Doctor Strange 2' scores one of the top launches of all time
- 05/15/22
- Box Office Battle: 'Doctor Strange 2' wins weekend with another $61M
- 05/10/22
- What You Missed This Week in Video Games
- $2,027.13 /
-125.73 (-5.84%) - 05/20/22
- What You Missed On Wall Street On Friday
- 08:30 Today
- Three new option listings and twelve option delistings on May 24th
- 05/19/22
- Zynga call volume above normal and directionally bullish
- 05/10/22
- Zynga put volume heavy and directionally bearish
- 05/04/22
- Zynga put volume heavy and directionally bearish
- $122.46 /
-1.175 (-0.95%) - 05/17/22
- Early notable gainers among liquid option names on May 17th
- 04/22/22
- TakeTwo Interactive Software call volume above normal and directionally bullish
- 02/07/22
- TakeTwo Interactive Software put volume heavy and directionally bearish
- 01/19/22
- Early notable gainers among liquid option names on January 19th
- 05/02/22
- Microsoft put buyer realizes 57% same-day gains
- 04/27/22
- Early notable gainers among liquid option names on April 27th
- 04/27/22
- Notable open interest changes for April 27th
- 04/26/22
- Microsoft call buyer realizes 19% same-day gains
- 05/11/22
- Early notable gainers among liquid option names on May 11th
- 02/22/22
- Electronic Arts call volume above normal and directionally bullish
- 02/01/22
- Electronic Arts options imply 5.5% move in share price post-earnings
- 01/20/22
- Electronic Arts call volume above normal and directionally bullish
- 05/11/22
- Disney options imply 8.5% move in share price post-earnings
- 05/09/22
- Unusually active option classes on open May 9th
- 04/20/22
- Unusually active option classes on open April 20th
- 02/10/22
- Early notable gainers among liquid option names on February 10th
- 05/09/22
- Comcast call volume above normal and directionally bullish
- 04/25/22
- Comcast put volume heavy and directionally bearish
- 04/21/22
- Comcast put volume heavy and directionally bearish
- 02/18/22
- Comcast put volume heavy and directionally bearish
- 05/02/22
- Unusually active option classes on open May 2nd
- 04/25/22
- Unusually active option classes on open April 25th
- 04/18/22
- Activision Blizzard call volume above normal and directionally bullish
- 02/04/22
- Notable open interest changes for February 4th
- $2,027.13 /
-125.73 (-5.84%) - 04/28/22
- Amazon options imply 5.5% move in share price post-earnings
- 03/10/22
- Early notable gainers among liquid option names on March 10th
- 02/04/22
- Early notable gainers among liquid option names on February 4th
- 08:55 Today
- Notable open interest changes for May 24th
- 08:00 Today
- Apple call buyer realizes 19% same-day gains
- 05/23/22
- Apple call volume above normal and directionally bullish
- 05/23/22
- Notable open interest changes for May 23rd
|